tirzepatide diabetes trial monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) SURPASS-CVOT Published: Large Trial Confirms
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22



























